Cannabis Science
Curated by SignalUS-Based, Public, clinical-stage Biotech developing phytocannabinoid-based pharmaceuticals for critical illnesses such as cancer
Overview
Cannabis Science is a US-Based, Public, clinical-stage Biotech developing phytocannabinoid-based pharmaceuticals for critical illnesses such as cancer. They currently have 3 lead candidates - CS-TATI-1, CS-S/BCC-1, CS-NEURO-1. CS-TATI-1 is indicated for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains or patients with intolerance to existing treatments. It is currently in Phase I as a topical drug and is under investigation for oral administration. CS-S/BCC-1 is indicated for topical administration for basal and squamous cell carcinomas. The drug is under discussion for an IND filing with the FDA. CS-NEURO-1 is in the preclinical phase for neurobehavioral disorders such as ADHD and anxiety.
Key facts
- Founded
- 1996
- Headquarters
- Irvine, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Contact
- Primary office
- Sign up to view
- Sign up to view